|
| | 
|
 | |
          
|  |
|  |
(Login BolsaPT & Canal Forex) |
|
 SCHERING PLOUGH C - [Ticker: SGP] |     | | Última Trade | 368,000 | Range 52 Semanas | [0,000 - 0,000] | | Hora da Última Trade | 2018-09-14 - 00:00:00 | Price-Target 1 Ano | 0,000 | | Variação | --10.00 (+0.97%) | Capitalização Bolsista | 0 | | Bid / Ask | N/A | EPS | 0,00 | | Abertura | 378,000 | PER | 0,00% | | Máximo | 378,000 | Pagamento Dividendo | | | Mínimo | 368,000 | Data Ex-Dividendo | | | Fecho Anterior | 378,000 | Yield | | | Volume | 420 | Volume Médio (3m) | 0 | | Nota: Os dados podem apresentar atraso de alguns minutos. |
| | Ver cotações de outros activos |
| Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C: | | Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C. |
|
Notícias sobre SCHERING PLOUGH C [SGP]: (ordenadas por relevância)
|
The Economist |
A pharmaceutical firm bets big on a cancer drugThe EconomistMerck's merger with another pharma firm, Schering-Plough, in 2009, had brought it an obscure new cancer drug. At first Merck's scientists were unimpressed and relegated the drug to a list of assets to be licensed out. There was widespread scepticism at ... |
|
Merck, Schering-Plough set to complete mergerReutersNEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE. |
The Pharmaceutical Journal |
Hepatitis C: tackling the silent killerThe Pharmaceutical Journal1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ... |
|
Dividend investors: You need to watch out for thisStansberry Churchouse Research (blog)With this strategy, Anne had amassed a US$22 million fortune by the time she passed away in 1995 ? including US$7.5 million worth of pharmaceutical company Schering-Plough shares and US$720,000 worth of Coca-Cola shares. Anne's story is just one ... |
|
Merck to buy Schering-Plough for $41.1 billionMarketWatchBefore the opening bell Monday, the two major drugmakers said they have agreed to a merger that calls for Schering-Plough SGP, -4.89% shareholders to receive $10.50 in cash and 0.5767 in Merck MRK, +0.63% stock for each share of Schering-Plough. |
|
Merck, Schering-Plough to complete merger TuesdayMarketWatchMRK, -0.53% and Schering-Plough Corp. SGP, -2.65% said they will complete their $41 billion merger after the market's close on Tuesday. As a result, Schering-Plough's stock will cease trading later Tuesday. The combined company will be known as Merck, ...e mais » |
RTE.ie |
Animal medicines company purchases Rathdrum siteRTE.ieThe world's largest manufacturer of animal medicines and vaccines has bought the former MSD pharmaceutical plant in Rathdrum, Co Wicklow. US-based company Zoetis, which already operates two sites in Ireland, confirmed to RTÉ News this evening it has ...e mais » |
| Para mais notícias sobre SCHERING PLOUGH C clique aqui:
Notícias de SCHERING PLOUGH C |
|
Largura do Site:
Imagem de Fundo: |
|  | |
|
|
![Gráfico de SCHERING PLOUGH C - [Ticker: SGP]](http://www.bolsapt.com/grafico/bolsapt-SGP-2-anos.png "Gráfico 2 Anos de SCHERING PLOUGH C [SGP] BolsaPT")
